ID

39394

Descrizione

A Study to Investigate the Pharmacodynamic and Pharmacokinetic Interaction Between Aliskiren and Furosemide in Patients With Heart Failure; ODM derived from: https://clinicaltrials.gov/show/NCT01125514

collegamento

https://clinicaltrials.gov/show/NCT01125514

Keywords

versioni (1)
  1. 07/01/20 07/01/20 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

7 gennaio 2020

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Heart Failure NCT01125514

Inglese

Eligibility Heart Failure NCT01125514

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
systolic or diastolic heart failure, diagnosed with either nyha functional class ii to iii at least 3 months prior to screening and on stable medication for at least 12 weeks.
Descrizione

Systolic Heart Failure Disease length New York Heart Association Classification | Diastolic Heart Failure Disease length New York Heart Association Classification | Pharmaceutical Preparations Stable

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1135191
UMLS CUI [1,2]
C0872146
UMLS CUI [1,3]
C1275491
UMLS CUI [2,1]
C1135196
UMLS CUI [2,2]
C0872146
UMLS CUI [2,3]
C1275491
UMLS CUI [3,1]
C0013227
UMLS CUI [3,2]
C0205360
patients must have met either of the criteria at screening:
Descrizione

Criteria Fulfill

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0243161
UMLS CUI [1,2]
C1550543
documented left ventricular ejection fraction (lvef) greater than 20% but lower than 40% or
Descrizione

Left ventricular ejection fraction

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0428772
patients with a documented lvef greater than 40% and with a history of nt-pro-bnp> 400pg/ml (or bnp > 100pg/ml) within 12 months of screening.
Descrizione

Left ventricular ejection fraction | Amino-terminal pro-brain natriuretic peptide Unit of Measurement | Brain natriuretic peptide measurement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0428772
UMLS CUI [2,1]
C0754710
UMLS CUI [2,2]
C1519795
UMLS CUI [3]
C1095989
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
treatment with angiotensin receptor blockers (arbs), aldosterone receptor antagonists and diuretics (other than furosemide) within 3 weeks of first dose and during the study. beta blockers were permitted provided the dose was stable for at least 3 weeks before the first dose and remains so throughout the study.
Descrizione

Angiotensin II receptor antagonist | Aldosterone Receptor Antagonists | Diuretics | Exception Furosemide

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0521942
UMLS CUI [2]
C1579268
UMLS CUI [3]
C0012798
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0016860
hypertrophic cardiomyopathy (hcmp).
Descrizione

Hypertrophic Cardiomyopathy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0007194
if a subject is currently treated with furosemide, the dose must be stable for at least 3 weeks before the first dose and the dose must not exceed 60 mg daily
Descrizione

Furosemide Dose Stable U/day

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0016860
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
UMLS CUI [1,4]
C0456683
stable heart failure requiring treatment with both an ace inhibitor and an arb or current acute decompensated heart failure.
Descrizione

Heart failure Stable | Requirement Angiotensin-Converting Enzyme Inhibitors | Requirement Angiotensin II receptor antagonist | Decompensated cardiac failure

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0018801
UMLS CUI [1,2]
C0205360
UMLS CUI [2,1]
C1514873
UMLS CUI [2,2]
C0003015
UMLS CUI [3,1]
C1514873
UMLS CUI [3,2]
C0521942
UMLS CUI [4]
C0581377
mean sitting systolic blood pressure ≥160 mmhg and/or mean sitting diastolic blood pressure ≥ 100mmhg and/or secondary forms of hypertension.
Descrizione

Sitting systolic blood pressure mean | Sitting diastolic blood pressure mean | Secondary hypertension

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1319893
UMLS CUI [1,2]
C0444504
UMLS CUI [2,1]
C1319894
UMLS CUI [2,2]
C0444504
UMLS CUI [3]
C0155616
persistent sitting systolic blood pressure <90 mmhg.
Descrizione

Sitting systolic blood pressure Persistent

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1319893
UMLS CUI [1,2]
C0205322
history of angioedema.
Descrizione

Angioedema

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0002994
other protocol-defined inclusion/exclusion criteria may apply
Descrizione

Eligibility Criteria Study Protocol

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
Ritorna all'inizio della pagina

Similar models

Eligibility Heart Failure NCT01125514

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Systolic Heart Failure Disease length New York Heart Association Classification | Diastolic Heart Failure Disease length New York Heart Association Classification | Pharmaceutical Preparations Stable
Item
systolic or diastolic heart failure, diagnosed with either nyha functional class ii to iii at least 3 months prior to screening and on stable medication for at least 12 weeks.
boolean
C1135191 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C1275491 (UMLS CUI [1,3])
C1135196 (UMLS CUI [2,1])
C0872146 (UMLS CUI [2,2])
C1275491 (UMLS CUI [2,3])
C0013227 (UMLS CUI [3,1])
C0205360 (UMLS CUI [3,2])
Criteria Fulfill
Item
patients must have met either of the criteria at screening:
boolean
C0243161 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
Left ventricular ejection fraction
Item
documented left ventricular ejection fraction (lvef) greater than 20% but lower than 40% or
boolean
C0428772 (UMLS CUI [1])
Left ventricular ejection fraction | Amino-terminal pro-brain natriuretic peptide Unit of Measurement | Brain natriuretic peptide measurement
Item
patients with a documented lvef greater than 40% and with a history of nt-pro-bnp> 400pg/ml (or bnp > 100pg/ml) within 12 months of screening.
boolean
C0428772 (UMLS CUI [1])
C0754710 (UMLS CUI [2,1])
C1519795 (UMLS CUI [2,2])
C1095989 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Angiotensin II receptor antagonist | Aldosterone Receptor Antagonists | Diuretics | Exception Furosemide
Item
treatment with angiotensin receptor blockers (arbs), aldosterone receptor antagonists and diuretics (other than furosemide) within 3 weeks of first dose and during the study. beta blockers were permitted provided the dose was stable for at least 3 weeks before the first dose and remains so throughout the study.
boolean
C0521942 (UMLS CUI [1])
C1579268 (UMLS CUI [2])
C0012798 (UMLS CUI [3])
C1705847 (UMLS CUI [4,1])
C0016860 (UMLS CUI [4,2])
Hypertrophic Cardiomyopathy
Item
hypertrophic cardiomyopathy (hcmp).
boolean
C0007194 (UMLS CUI [1])
Furosemide Dose Stable U/day
Item
if a subject is currently treated with furosemide, the dose must be stable for at least 3 weeks before the first dose and the dose must not exceed 60 mg daily
boolean
C0016860 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0456683 (UMLS CUI [1,4])
Heart failure Stable | Requirement Angiotensin-Converting Enzyme Inhibitors | Requirement Angiotensin II receptor antagonist | Decompensated cardiac failure
Item
stable heart failure requiring treatment with both an ace inhibitor and an arb or current acute decompensated heart failure.
boolean
C0018801 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C1514873 (UMLS CUI [2,1])
C0003015 (UMLS CUI [2,2])
C1514873 (UMLS CUI [3,1])
C0521942 (UMLS CUI [3,2])
C0581377 (UMLS CUI [4])
Sitting systolic blood pressure mean | Sitting diastolic blood pressure mean | Secondary hypertension
Item
mean sitting systolic blood pressure ≥160 mmhg and/or mean sitting diastolic blood pressure ≥ 100mmhg and/or secondary forms of hypertension.
boolean
C1319893 (UMLS CUI [1,1])
C0444504 (UMLS CUI [1,2])
C1319894 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
C0155616 (UMLS CUI [3])
Sitting systolic blood pressure Persistent
Item
persistent sitting systolic blood pressure <90 mmhg.
boolean
C1319893 (UMLS CUI [1,1])
C0205322 (UMLS CUI [1,2])
Angioedema
Item
history of angioedema.
boolean
C0002994 (UMLS CUI [1])
Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial